32 results
8-K
EX-99.2
PCSA
Processa Pharmaceuticals Inc
12 Oct 17
Entry into a Material Definitive Agreement
12:00am
States of America. We have perfumed a compilation engagement in accordance with Statements on Standards for Accounting and Review Services promulgated
8-K
EX-99.1
PCSA
Processa Pharmaceuticals Inc
13 Oct 20
Processa Pharmaceuticals Announces Appointment of Michael Floyd as Chief Operating Officer
9:30am
and safely attack high-value milestones. Elion sought out a collaborative engagement with the very best development partners and we found that partner
8-K
PCSA
Processa Pharmaceuticals Inc
18 Feb 21
Processa Pharmaceuticals Announces $10.2 Million Strategic Financing
10:08am
conditions.
The Company engaged Tribal Capital Markets, LLC (“Tribal”) as placement agent for the Offering pursuant to an engagement letter agreement
8-K
EX-4.3
o8qm5sq7
30 Jan 24
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
10:46am
424B4
zy7er109i3 9obqb
29 Jan 24
Prospectus supplement with pricing info
4:15pm
DEF 14A
kcpt43
26 Apr 19
Definitive proxy
5:02pm
10-K
EX-3.2
1w3zz
27 Mar 14
Annual report
12:00am